Natera, Inc. vs Pfizer, Inc. — Stock Comparison

NTRA
Natera, Inc.
$207.28
▲ 0.54%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 6/10

Q·Score Breakdown

6
Neutral
Overall
6.5
Neutral
2.5
Quality
7.4
8.7
Health
7
6.8
Growth
5.6
5
Valuation
6.7
8.2
Sentiment
5.2
NTRA

Clean balance sheet with low leverage (0.1× debt-to-equity).

currently unprofitable (-9% margin).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

BUY
Target $258.00 (+24.5%)
18 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

NTRA
PFE
Trailing P/E
19.4×
-305.6×
Forward P/E
9.4×
-9.0%
Profit Margin
12.4%
64.7%
Gross Margin
75.8%
-14.3%
ROE
8.9%
39.8%
Revenue Growth
-1.2%
Earnings Growth
1.68
Beta
0.39
Price / Book
$29.6B
Market Cap
$149.8B
$132 – $256
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →